{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:44:29Z","timestamp":1773236669435,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","award":["GOIPG\/2017\/1659"],"award-info":[{"award-number":["GOIPG\/2017\/1659"]}],"id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.tranon.2022.101381","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T12:42:33Z","timestamp":1646138553000},"page":"101381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2278-5497","authenticated-orcid":false,"given":"Maria","family":"Davern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1275-5083","authenticated-orcid":false,"given":"Marie-Claire","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-5775","authenticated-orcid":false,"given":"Cro\u00ed E.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7325-259X","authenticated-orcid":false,"given":"Aisling B.","family":"Heeran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel E.","family":"Donlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-9876","authenticated-orcid":false,"given":"Jason","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-4374","authenticated-orcid":false,"given":"Fiona","family":"O\u2019 Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malvika R.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2791-039X","authenticated-orcid":false,"given":"Conall","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John V.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-7906","authenticated-orcid":false,"given":"Stephen G.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh","family":"Lynam-Lennon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6740-8858","authenticated-orcid":false,"given":"Brona","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3363-3763","authenticated-orcid":false,"given":"Joanne","family":"Lysaght","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2022.101381_bib0001","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2022.101381_bib0002","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1245\/s10434-017-5858-7","article-title":"Expression of programmed cell death protein 1 by tumor-infiltrating lymphocytes and tumor cells is associated with advanced tumor stage in patients with esophageal adenocarcinoma","volume":"24","author":"Kollmann","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.tranon.2022.101381_bib0003","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41416-018-0298-0","article-title":"Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer","volume":"120","author":"Gao","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tranon.2022.101381_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162925","article-title":"Elevated cellular PD1\/PD-L1 expression confers acquired resistance to cisplatin in small cell lung cancer cells","volume":"11","author":"Yan","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tranon.2022.101381_bib0005","doi-asserted-by":"crossref","first-page":"e53834","DOI":"10.1371\/journal.pone.0053834","article-title":"Tim-3 expression in cervical cancer promotes tumor metastasis","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tranon.2022.101381_bib0006","doi-asserted-by":"crossref","first-page":"e81799","DOI":"10.1371\/journal.pone.0081799","article-title":"Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tranon.2022.101381_bib0007","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41416-018-0313-5","article-title":"VISTA expressed in tumour cells regulates T cell function","volume":"120","author":"Mulati","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tranon.2022.101381_bib0008","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1158\/1078-0432.CCR-17-2542","article-title":"Spatially resolved and quantitative analysis of VISTA\/PD-1H as a novel immunotherapy target in human non\u2013small cell lung cancer","volume":"24","author":"Villarroel-Espindola","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2022.101381_bib0009","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.3389\/fimmu.2018.02821","article-title":"Intrinsic expression of immune checkpoint molecule TIGIT could help tumor growth in vivo by suppressing the function of NK and CD8+ T cells","volume":"9","author":"Zhou","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2022.101381_bib0010","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2022.101381_bib0011","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41467-017-01883-9","article-title":"DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells","volume":"8","author":"Sato","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2022.101381_bib0012","doi-asserted-by":"crossref","first-page":"e53834","DOI":"10.1371\/journal.pone.0053834","article-title":"Tim-3 expression in cervical cancer promotes tumor metastasis","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tranon.2022.101381_bib0013","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12032-015-0655-2","article-title":"PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma","volume":"32","author":"Wang","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.tranon.2022.101381_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101062","article-title":"Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells","volume":"14","author":"Davern","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tranon.2022.101381_bib0015","doi-asserted-by":"crossref","first-page":"781","DOI":"10.21037\/tcr.2016.12.01","article-title":"Programmed death 1 induces cell chemoresistance to 5-fluorouracil in gastric cancer cell lines","volume":"5","author":"Liu","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.tranon.2022.101381_bib0016","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1038\/s41598-020-68777-7","article-title":"Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib","volume":"10","author":"Buckley","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2022.101381_bib0017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41420-021-00401-7","article-title":"Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment","volume":"7","author":"Yu","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.tranon.2022.101381_bib0018","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13046-019-1407-5","article-title":"Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer","volume":"38","author":"Kim","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2022.101381_bib0019","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2022.101381_bib0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2019.06.013","article-title":"Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61\/CTGF via the hippo pathway","volume":"460","author":"Pu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2022.101381_bib0021","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-04-2490","article-title":"Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation","volume":"65","author":"Kimchi","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2022.101381_bib0022","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fimmu.2021.645699","article-title":"Immune checkpoints, a novel class of therapeutic targets for autoimmune diseases","volume":"12","author":"Zhai","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2022.101381_bib0023","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.tranon.2022.101381_bib0024","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/cts.12304","article-title":"Animal models of Barrett's esophagus and esophageal adenocarcinoma\u2013past, present, and future","volume":"8","author":"Kapoor","year":"2015","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.tranon.2022.101381_bib0025","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s43018-020-0075-x","article-title":"PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer","volume":"1","author":"Oh","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tranon.2022.101381_bib0026","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tranon.2022.101381_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001199","article-title":"PD-L1 signaling on human memory CD4+ T cells induces a regulatory phenotype","volume":"19","author":"Fanelli","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tranon.2022.101381_bib0028","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.imbio.2015.08.003","article-title":"TIGIT negatively regulates inflammation by altering macrophage phenotype","volume":"221","author":"Chen","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.tranon.2022.101381_bib0029","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4251\/wjgo.v13.i5.312","article-title":"Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers","volume":"13","author":"King","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.tranon.2022.101381_bib0030","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.3390\/cancers12123802","article-title":"Characteristics of the tumor microenvironment that influence immune cell functions: hypoxia, oxidative stress, metabolic alterations","volume":"12","author":"Augustin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tranon.2022.101381_bib0031","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1172\/JCI80445","article-title":"TIGIT and PD-1 impair tumor antigen\u2013specific CD8+ T cells in melanoma patients","volume":"125","author":"Chauvin","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tranon.2022.101381_bib0032","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2022.101381_bib0033","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13046-020-01818-1","article-title":"PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2\/Ras\/MAPK signalling in thyroid cancer cells","volume":"40","author":"Liotti","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2022.101381_bib0034","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3389\/fimmu.2018.01774","article-title":"Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy","volume":"9","author":"Yao","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2022.101381_bib0035","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.29360","article-title":"Programmed cell death-1 (PD-1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell-intrinsic PD-1","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.tranon.2022.101381_bib0036","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13550-018-0433-1","article-title":"Anti PD-1 treatment increases [18F]FDG uptake by cancer cells in a mouse B16F10 melanoma model","volume":"8","author":"Tomita","year":"2018","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.tranon.2022.101381_bib0037","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jconrel.2021.06.001","article-title":"A clinically acceptable strategy for sensitizing anti-PD-1 treatment by hypoxia relief","volume":"335","author":"Jiang","year":"2021","journal-title":"J. Control. Rel."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523322000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523322000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:23:05Z","timestamp":1761844985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523322000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":37,"alternative-id":["S1936523322000432"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2022.101381","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2022.101381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101381"}}